Cite
MLA Citation
Russell Garland et al.. “6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A3–A4. http://access.bl.uk/ark:/81055/vdc_100144716975.0x000003